Sanofi-Aventis (France) Loses Bid to Ditch U.S. Suit on Failed Drug

April 1, 2011 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

PARIS, March 31 (Reuters) - Sanofi-Aventis (SASY.PA) lost a bid to dismiss a U.S. lawsuit launched by an investor for allegedly withholding information on its flopped anti-obesity pill Acomplia, which was once seen as a potential blockbuster.

Twitter
LinkedIn
Facebook
Email
Print

Legal Europe

Sanofi (France)